A5006350690- HIV/AIDS drug development and treatment
- HIV-related health complications and treatments
- Hepatitis C virus research
- HIV Research and Treatment
- Cancer Treatment and Pharmacology
- Hepatitis B Virus Studies
- Chronic Lymphocytic Leukemia Research
- Cancer, Stress, Anesthesia, and Immune Response
- Cancer survivorship and care
- Family Support in Illness
- Childhood Cancer Survivors' Quality of Life
- HIV/AIDS Research and Interventions
- Pneumocystis jirovecii pneumonia detection and treatment
- Animal Disease Management and Epidemiology
- Lymphoma Diagnosis and Treatment
- Ethics in medical practice
- Peripheral Nerve Disorders
- Viral-associated cancers and disorders
- Bipolar Disorder and Treatment
- Liver Diseases and Immunity
- HIV, Drug Use, Sexual Risk
- Renal Diseases and Glomerulopathies
- Pain Management and Opioid Use
- Vascular anomalies and interventions
- Polyomavirus and related diseases
Hôpital Pellegrin
2025
Médecins du Monde
2025
Hôpital Paul-Brousse
2025
Université de Strasbourg
2009-2024
Universidad Nacional de Colombia
2023
Hôpitaux Universitaires de Strasbourg
2007-2021
Centre Hospitalier Universitaire de Nantes
2018
Southeastern Health
2010
Hôpital Pasteur
2008
The aim of this study was to determine characteristics patients who reported a strengthening their couple relationship 2 years after cancer diagnosis. Using cross-sectional design, data were obtained from representative sample with primary diagnosis cancer. Medical and collected by physicians patient telephone interview respectively. Among the 3221 participants living same partner as at time diagnosis, 32.8% men 41.5% women declared illness had brought them closer partner. following factors...
We read with great interest the recent paper from Martín-Carmona et al., who found that HIV does not increase mortality risk after hepatitis C virus (HCV) cure direct-acting antivirals (DAA) in people advanced liver fibrosis [1].By publishing long-term followup data, authors provide valuable insights into unresolved question of whether or increases HCV cure.
Many antiretroviral therapies, including efavirenz, are associated with increased serum concentrations of low-density lipoprotein cholesterol. In a small 52-week randomized study, we found that switching from efavirenz to nevirapine was significantly decreased cholesterol levels, compared continuation therapy (P < .04). A switch no severe adverse events.
To identify main prognostic factors for 5-year mortality among age-related comorbidities (ARCs) in older people living with HIV (PLHIV).
Although antiretroviral therapy (ART) has reduced the risk of Kaposi sarcoma (KS), KS cases still occur in HIV-infected people.To describe all observed between 2010 and 2015 a country with high ART coverage.Retrospective study using longitudinal data from 44 642 patients French Dat'AIDS multicenter cohort. Patients' characteristics were described at diagnosis according to exposure HIV-plasma viral load (HIV-pVL) (≤50 or >50) copies/mL.Among 209 diagnosed during period, 33.2% occurred naïve...
The aim was to investigate the impact of main prognostic factors on HIV evolution. A multi-state Markov model applied in a cohort 2126 patients estimate these patients' clinical and immunological evolutions. Clinical progression deterioration shared most their factors: male gender, intravenous drug use, weight loss, low haemoglobin level (<110 g/l), CD8 cell count (<500/mm(3)) viral load (>5 log(10) copies/ml). Highly active retroviral therapy reduced risks immune whatever CD4 count. Risk...
Both human immunodeficiency virus (HIV) and hepatitis C (HCV) infections have been reportedly associated with a higher risk of diabetes mellitus (DM) but results are conflicting.To determine whether there is an association between chronic HCV the incidence DM, to study role factors such as cirrhosis, IFN-based therapy, sustained virologic response (SVR) HBV infection among patients living HIV (PLHIV) followed in large French multicentre cohort combination antiretroviral therapy (cART)...
Dairy production systems are a sensitive sector of the primary economy frequently affected by pathogens that negatively impact parameters, bovine leukemia virus (BLV) one these. In this study, molecular prevalence BLV was determined in specialized dairy Antioquia using viral marker envelope gene (env). Blood samples were taken from 575 bovines dairies distributed 53 herds and located three milk areas (north, east, Valle de Aburrá). DNA extraction performed salting out, nested PCR to detect...
Abstract Background Assessing the potential increased risk of viral rebound (VR) in migrants requires adequate control for sex and acquisition groups. Methods People living with HIV1, enrolled ANRS CO4‐French Hospital Database on HIV, who achieved virological suppression antiretroviral therapy (ART) initiated between 2006 2016 were included. We first compared VR, loss to follow‐up death considered as competing events, across origin among HIV groups, then groups different origins, finally...